Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00166179 |
Recruitment Status
:
Completed
First Posted
: September 14, 2005
Last Update Posted
: September 26, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Coronary Artery Disease |
Study Type : | Observational |
Actual Enrollment : | 57 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI |
Study Start Date : | November 2003 |
Actual Primary Completion Date : | October 2006 |
Actual Study Completion Date : | October 2006 |

- Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI [ Time Frame: time of initial scans ]
- Compare size of regions of viable and non viable myocardium as % left ventricle by MRI vs. PET [ Time Frame: at time of initial scans ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 95 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- PET-FDG ordered to assess myocardial viability
Exclusion Criteria:
- Contraindicated for MRI
- Pregnant
- Age <25 yrs

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00166179
United States, Georgia | |
Crawford Long Hospital | |
Atlanta, Georgia, United States, 30308 |
Principal Investigator: | Randolph Patterson, MD | Staff |
Responsible Party: | Randolph E Patterson, Professor, Emory University |
ClinicalTrials.gov Identifier: | NCT00166179 History of Changes |
Other Study ID Numbers: |
IRB00000292 6-56550 ( Other Identifier: Other ) |
First Posted: | September 14, 2005 Key Record Dates |
Last Update Posted: | September 26, 2014 |
Last Verified: | September 2014 |
Keywords provided by Randolph E Patterson, Emory University:
CAD |
Additional relevant MeSH terms:
Coronary Artery Disease Myocardial Ischemia Coronary Disease Heart Diseases |
Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases |